ADMA Biologics, Inc. (NASDAQ:ADMA) Q2 2025 Earnings Call Transcript August 6, 2025
ADMA Biologics, Inc. beats earnings expectations. Reported EPS is $0.15, expectations were $0.14.
Operator: Good afternoon, and welcome to the ADMA Biologics Second Quarter 2025 Financial Results and Business Update Conference Call on Wednesday, August 6, 2025. [Operator Instructions] Please be advised that this call is being recorded at the company’s request and will be available on the company’s website...
